Referanslar

1. Terry TL. Extreme prematurity and fibroblastic over- growth of persistent vascular sheath behind each crystalline lens I. Am J Ophthalmol 1942;25:203-4. [Crossref]
2. National Eye Institute. Retinopathy of prematurity (ROP). Last reviewed; June 2014. [Link]
3. Provis JM, Leech J, Diaz CM, et al. Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res 1997;65:555-68. [Crossref]  [PubMed]
4. Gerhardt H, Golding M, Fruttiger M, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003;161:1163-77. [Crossref]  [PubMed]  [PMC]
5. Smith LEH. IGF-1 and retinopathy of prematurity in the preterm infant. Biol Neonate 2005;88:237-44. [Crossref]  [PubMed]
6. Lad EM, Cheshier SH, Kalani MYS. Wnt-signaling in retinal development and disease. Stem Cells Dev 2009;18:7-16. [Crossref]  [PubMed]
7. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust 1951;2:48-50. [Crossref]  [PubMed]
8. Patz A, Hoeck LE, De La Cruz. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol 1952;35:1248-53. [Crossref]  [PubMed]
9. Patz A, Eastham A, Higginbotham DH, et al. Oxygen studies in retrolental fibroplasia. Am J Ophthalmol 1953;36:1511-22. [Crossref]  [PubMed]
10. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-in- duced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994;35:101-11. [PubMed]
11. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothe-lial growth factor in ocular fluid of patients with diabet- ic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7 [Crossref]  [PubMed]
12. Sonmez K, Drenser KA, Capone A, et al. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity. Ophthalmology 2008;115:1065-70.e1. [Crossref]  [PubMed]
13. Sato T, Wada K, Arahori H, et al. Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Oph- thalmol 2012;153:327-33.e1. [Crossref]  [PubMed]
14. Mintz-Hittner HA, Kennedy KA, Chuang AZ, et al. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011;364:603-15. [Crossref]  [PubMed]  [PMC]
15. Hartnett ME, Morrison MA, Smith S, et al. Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infants. Invest Ophthalmol Vis Sci 2014;55:6194-203. [Crossref]  [PubMed]  [PMC]
16. Chen ZY, Battinelli EM, Fielder A, et al. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet 1993;5:180-3. [Crossref]  [PubMed]
17. Shastry BS, Pendergast SD, Hartzer MK, et al. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol 1997;115:651-5. [Crossref]  [PubMed]
18. An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol. [Crossref]
19. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOPROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000;105:295- 310. [Crossref]  [PubMed]
20. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited, in: Arch Ophthalmol. Archmerican Medical Association 2005;991-9. [Crossref]  [PubMed]
21. Wallace DK, Freedman SF, Hartnett ME, et al. Predictive value of prplus disease in retinopathy of prematurity. Arch Ophthalmol 2011;129:591-6. [Crossref]  [PubMed]  [PMC]
22. Drenser KA, Trese MT, Capone A. Aggressive posterior retinopathy of prematurity. Retina 2010;30:S37-40. [Crossref]  [PubMed]
23. Kychenthal A, Dorta P, Katz X. Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes. Reti- na 2006;26:S11-15. [Crossref]  [PubMed]
24. Vinekar A, Trese MT, Capone A, et al. Evolution of retinal detachment in posterior retinopathy of prematurity: impact on treatment approach. Am J Ophthalmol 2008;145:548-555. [Crossref]  [PubMed]
25. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1988;106:471-9. [Crossref]  [PubMed]
26. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome-structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1990;108:1408-16. [Crossref]  [PubMed]
27. Schwartz SD, Harrison SA, Ferrone PJ, et al. Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera. Ophthalmology 2000;107:25-8. [Crossref]  [PubMed]
28. Fierson WM,Capone A. American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association of Certified Orthoptists, Telemedicine for evaluation of retinopathy of prematurity. Pediatrics 2015;135: e238-54. [Crossref]  [PubMed]
29. Quinn GE, e-ROP Cooperative Group. Telemedicine ap- proaches to evaluating acutephase retinopathy of prematurity: study design. Ophthalmic Epidemiol 2014;21:256-67. [Crossref]  [PubMed]  [PMC]
30. Wang SK, Callaway NF, Wallenstein MB, et al. SUN- DROP: six years of screening for retinopathy of prematurity with telemedicine. Can J Ophthalmol 2015;50:101-6. [Crossref]  [PubMed]
31. Ells AL, Holmes JM, Astle WF, et al. Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study. Ophthalmology 2003;110:2113-17. [Crossref]  [PubMed]
32. Chiang MF, Keenan JD, Starren J, et al. Accuracy and reliability of remote retinopathy of prematurity diagnosis. Arch Ophthalmol 2006;124:322-7. [Crossref]  [PubMed]
33. Wu C, Petersen RA, VanderVeen DK. RetCam imaging for retinopathy of prematurity screening. J AAPOS 2006;10:107-11. [Crossref]  [PubMed]
34. Chiang MF, Wang L, Busuioc M, et al. Telemedical retinopathy of prematurity diagnosis: accuracy, reliability, and image quality. Arch Ophthalmol 2007;125:1531-8. [Crossref]  [PubMed]
35. Repka MX, Tung B, Good WV, et al. Outcome of eyes developing retinal detachment during the early treatment for retinopathy of prematurity study (ETROP). Arch Ophthal- mol 2006;124:24-30. [Crossref]  [PubMed]
36. Trese MT. Scleral buckling for retinopathy of prematurity. Ophthalmology 1994;101: 23-6. [Crossref]  [PubMed]
37. Trese M. Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity. Ophthalmology 1998;105:992-7. [Crossref]  [PubMed]
38. Chow DR, Ferrone PJ, Trese MT. Refractive changes associated with scleral buckling and division in retinopathy of prematurity. Arch Ophthalmol 1998;116:1446-8. [Crossref]  [PubMed]
39. Maguire AM, Trese MT. Lens-sparing vitreoretinal surgery in infants. Arch Ophthalmol 1992;110:284-6. [Crossref]  [PubMed]
40. Capone A. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments. Ophthalmology 2001;108:2068-70. [Crossref]  [PubMed]
41. Hubbard GB III, Cherwick DH, Burian G. Lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Ophthalmol- ogy 2004;111:2274-7.e1. [Crossref]  [PubMed]
42. Stahl A, Lepore D, Fielder A, Fleck B, Reynolds JD, Chiang MF, Li J, et al. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet. 2019 Oct 26;394(10208):1551-1559.Epub 2019 Sep 12. [Crossref]  [PubMed]
43. Stahl A, Sukgen EA, Wu WC, Lepore D, Nakanishi H, Mazela J, Moshfeghi DM, et al. Effect of Intravitreal Af- libercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial. JAMA. 2022 Jul 26;328(4):348-359. [Crossref]  [PubMed]  [PMC]
44. Wu WC, Drenser KA, Lai M, et al. Plasmin enzyme-assist- ed vitrectomy for primary and reoperated eyes with stage 5 retinopathy of prematurity. Retina 2008;28:S75-80. [Crossref]  [PubMed]
45. Schepens CL. Clinical and research aspects of subtotal open- sky vitrectomy. XXXVII Edward Jackson memorial lecture. Am J Ophthalmol. 1981;91(2):143-71. Tasman W, Patz A, McNamara JA, et al. Retinopathy of prematurity: the life of a lifetime disease. Am J Ophthalmol 2006;141:167-74. [Crossref]  [PubMed]
46. Hirose T, Lou PL. Retinopathy of prematurity. Int Ophthalmol Clin. 1986;26(2):1-23. [Crossref]  [PubMed]
47. Hirose T, Schepens CL, Katsumi O, Mehta MC. Opensky vitrectomy for severe retinal detachment caused by advanced retinopathy of prematurity. In: Flynn J, editor. Retinopathy of prematurity. New York: Springer; 1992. p. 95-114. [Crossref]
48. Tasman W, Borrone RN, Bolling J. Open sky vitrectomy for total retinal detachment in retinopathy of prematurity. Ophthalmology. 1987;94(4):449-52. [Crossref]  [PubMed]
49. Brown AC, & Nwanyanwu K. (2023). Retinopathy of Prematurity. In StatPearls. StatPearls Publishing. [PubMed]
50. Steidl SM, Hirose T. Subretinal organization in stage 5 retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2003;241(4):263-8. [Crossref]  [PubMed]
51. Futamura Y, Asami T, Nonobe N, Kachi S, Ito Y, Sato Y, et al. Buckling surgery and supplemental intravitreal bevacizumab or photocoagulation on stage 4 retinopathy of prematurity eyes. Jpn J Ophthalmol. 2015;59(6):378-88. [Crossref]  [PubMed]
52. Topilow HW, Ackerman AL, Wang FM. The treatment of advanced retinopathy of prematurity by cryotherapy and scleral buckling surgery. Ophthalmology. 1985;92(3):379-87.19. McPherson A, Hittner HM. Scleral buckling in 2 1/2- to 11-month-old premature infants with retinal detachment a sociated with acute retrolental fibroplasia. Ophthalmology. 1979;86(5):819-36. [Crossref]  [PubMed]
53. Ricci B, Santo A, Ricci F, Minicucci G, Molle F. Scleral buckling surgery in stage 4 retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 1996;234(1):S38-41. [Crossref]  [PubMed]
54. Multicenter trial of cryotherapy for retinopathy of prematurity: one-year outcome-structure and function. Arch Ophthalmol. 1990;108(10):1408-16. [Crossref]  [PubMed]
55. Yokoi T, Yokoi T, Kobayashi Y, Hiraoka M, Nishina S, Azuma N. Evaluation of scleral buckling for stage 4A retinopathy of prematurity by fluorescein angiography. Am J Ophthal- mol. 2009;148(4):544-50.e1 [Crossref]  [PubMed]
56. Klufas MA, Patel SN, Chan RVP. Surgical management of retinopathy of prematurity. Dev Ophthalmol. 2014;54:223-33. [Crossref]  [PubMed]
57. Shah PK, Narendran V, Kalpana N, Tawansy KA. Anatomical and visual outcome of stages 4 and 5 retinopathy of prematurity. Eye (Lond). 2009;23(1): 176-80. [Crossref]  [PubMed]
58. Quinn GE, Dobson V, Barr CC, Davis BR, Flynn JT, Palmer EA, et al. Visual acuity in infants after vitrectomy for severe retinopathy of prematurity. Ophthalmology. 1991;98(1):5-13. [Crossref]  [PubMed]
59. Katsumi O, Mehta MC, Matsui Y, Tetsuka H, Hirose T. Development of vision in retinopathy of prematurity. Arch Ophthalmol. 1991;109(10):1394-8. [Crossref]  [PubMed]